Abstract
A simple, sensitive and specific chemiluminescence enzyme immunoassay based on biotin–streptavidin system (BASA-CLEIA) for diclazuril was established, which was about 2 and 4 times more sensitive than the traditional chemiluminescence enzyme immunoassay (CLEIA) and enzyme-linked immunosorbent assay. In the optimized generic assay, the half maximal inhibitory concentration (IC50) of the BASA-CLEIA for diclazuril was 0.48 μg/kg. The limit of detection for diclazuril was 0.02 μg/kg. This method showed no cross reactivity (<0.01%) with toltrazuril, robenidine hydrochloride, nicarbazin, halofuginone, amprolium, monensin, and maduramycin. In chicken muscles, the average recoveries ranged from 90.3% to 120.4%. A further comparison between the developed BSAS-CLEIA and high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method for real samples showed good correlation (p < 0.01). The results indicated that the simple, sensitive and specific BASA-CLEIA method could be used for the analysis of diclazuril in real samples.
Author supplied keywords
Cite
CITATION STYLE
Li, Y., Wang, Y., Li, P. P., Zhang, Y., Ke, Y., Yu, W., … Yu, X. (2020). High efficient chemiluminescent immunoassays for the detection of diclazuril in chicken muscle based on biotin–streptavidin system. Food and Agricultural Immunology, 31(1), 255–267. https://doi.org/10.1080/09540105.2020.1713054
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.